WomanTIDE PLUS forte: A European-certified study for women's health.
The research was conducted in 2022 by certified specialists from the Regenerative Medicine and Nutritional Medicine Department of the European Scientific Society at the Academy of Natural Sciences (Hanover).
To evaluate the effectiveness of the multi-component enhanced-action bioregulator "WomanTIDE PLUS" with peptides, designed for the female reproductive system, a study was conducted involving randomly selected patients who consulted a physician specializing in regenerative medicine, knowledgeable in and applying functional diagnostics, laser therapy, acupuncture, and bioresonance therapy methods.
The study involved ten female patients aged 22-38 who complained of painful, irregular, heavy menstrual bleeding, headaches, and mood swings during menstruation. Patients were prescribed the bioregulator "WomanTIDE PLUS forte" at a dosage of 1-2 capsules per day for 30-45 days, depending on their complaints and the intensity of pain symptoms.
After a course of the "WomanTIDE PLUS forte" bioregulator, all patients felt significantly better before and during menstruation, experienced less menstrual pain, had lighter periods, and their hormonal balance normalized.
No side effects, complications, or drug dependence were observed in patients who completed a course of the multi-component peptide bioregulator "WomanTIDE PLUS".
Source of information: https://myrealway.com/womantide-forte-peptides-for-women
